Claire Machin, the industry bodys executive director of international policy and UK competitiveness, said developing drugs was a high-risk process, with the average cost of taking a medicine from discovery to launch put at $2.3bn last year
Metformin can help with weight loss in PCOS patients by improving insulin sensitivity, but results are dose-dependent and won't work for everyone, especially those with advanced insulin resistance
The maker of Wegovy and Ozempic, Novo Nordisk, has predicted a sharp drop in revenues this year owing to what its boss described as a painful push by Donald Trump to lower US weight-loss drug prices, rising competition, and the loss of important patent protections
Metabolic Support
Not on your own
Pfizer Inc., Amgen Inc., and Boehringer Ingelheim International GmbH enhance their positions by developing novel therapies and collaborating with other companies for strategic market growth